{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:25:44Z","timestamp":1789863944835,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"British Columbia Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.josat.2024.209341","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T03:29:32Z","timestamp":1710386972000},"page":"209341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study"],"prefix":"10.1016","volume":"161","author":[{"given":"Bernadette (Bernie)","family":"Pauly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Macevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Kalicum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Gudi\u00f1o","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Urbanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Slaunwhite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.josat.2024.209341_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2024.209341_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108418","article-title":"Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada","volume":"130","author":"Bardwell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209341_bb0015","doi-asserted-by":"crossref","unstructured":"Bardwell, G., W., S., Lavalley, J., McNeil, R., & Kerr, T. (2021b). \"People need them or else they're going to take fentanyl and die\": A qualitative study examining the 'problem' of prescription opioid diversion during an overdose epidemic. Social Science and Medicine, 279. doi:https:\/\/doi.org\/10.1016\/j.socscimed.2021.113986.","DOI":"10.1016\/j.socscimed.2021.113986"},{"issue":"6","key":"10.1016\/j.josat.2024.209341_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","article-title":"The opioid crisis in Canada: A national perspective","volume":"38","author":"Belzak","year":"2018","journal-title":"Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice"},{"key":"10.1016\/j.josat.2024.209341_bb0025","unstructured":"BC Vital Statistics Agency [creator] (2018): Vital statistics deaths. British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108248","article-title":"The association between opioid discontinuation and heroin use: A nested case-control study","volume":"217","author":"Binswanger","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209341_bb0045","doi-asserted-by":"crossref","first-page":"102938","DOI":"10.1016\/j.drugpo.2020.102938","article-title":"Heroin and the illegal drug overdose death epidemic: A history of missed opportunities and resistance","volume":"91","author":"Boyd","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2024.209341_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"key":"10.1016\/j.josat.2024.209341_bb0060","unstructured":"British Columbia Coroners Service. (2022, August 16). Illicit drug toxicity deaths in BC: January 1, 2012 to December, 2021. Retrieved from https:\/\/www2.gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug.pdf."},{"key":"10.1016\/j.josat.2024.209341_bb0065","unstructured":"British Columbia Center for Disease Control. Opioid use disorder among youth in BC. http:\/\/www.bccdc.ca\/resource-gallery\/Documents\/Statistics%20and%20Research\/Statistics%20and%20Reports\/Overdose\/2023.06.06_OUD_youth_infographic.pdf."},{"key":"10.1016\/j.josat.2024.209341_bb0055","author":"British Columbia Centre on Substance Use"},{"key":"10.1016\/j.josat.2024.209341_bb0070","author":"British Columbia Centre on Substance Use"},{"key":"10.1016\/j.josat.2024.209341_bb0075","series-title":"A guideline for the clinical management of opioid use disorder","author":"British Columbia Centre on Substance Use","year":"2017"},{"key":"10.1016\/j.josat.2024.209341_bb0080","author":"British Columbia Coroners Service"},{"key":"10.1016\/j.josat.2024.209341_bb0085","unstructured":"British Columbia Coroners Service. (2022, December). Illicit drug toxicity type of drug data https:\/\/www2.gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug-type.pdf."},{"key":"10.1016\/j.josat.2024.209341_bb0090","author":"British Columbia Coroners Service"},{"key":"10.1016\/j.josat.2024.209341_bb0095","unstructured":"British Columbia Coroners Service. (2023b, June). Youth unregulated drug toxicity dreaths in British Columbia: January 1, 2017 \u2013 December 31, 2022. https:\/\/www2.gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/youth_drug_toxicity_deaths_2017-2022.pdf."},{"key":"10.1016\/j.josat.2024.209341_bb0100","unstructured":"British Columbia Ministry of Health [creator] (2018a): Discharge Abstract Database (hospital separations). British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0105","unstructured":"British Columbia Ministry of Health [creator] (2018b): Medical Services Plan (MSP) payment information file. British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0110","unstructured":"British Columbia Ministry of Health [creator] (2018c): National Ambulatory Care Reporting System (NACRS). British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0115","unstructured":"British Columbia Ministry of Health [creator] (2018d): PharmaNet. British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0125","author":"Canadian Association of People who Use Drugs"},{"issue":"5","key":"10.1016\/j.josat.2024.209341_bb0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"Chronic Disease"},{"issue":"8","key":"10.1016\/j.josat.2024.209341_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00005650-199508000-00004","article-title":"A chronic disease score with empirically derived weights","volume":"33","author":"Clark","year":"1995","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2024.209341_bb0140","author":"College of Pharmacists of British Columbia"},{"key":"10.1016\/j.josat.2024.209341_bb0145","author":"College of Pharmacists of British Columbia"},{"key":"10.1016\/j.josat.2024.209341_bb0150","unstructured":"College of Physicians and Surgeons of British Columbia. (2020\/2021). Committee reports: Diagnostic Accredition Program Committee. https:\/\/www.cpsbc.ca\/files\/pdf\/2020-21-AR-Committee-Reports.pdf."},{"key":"10.1016\/j.josat.2024.209341_bb0155","unstructured":"College of Physicians and Surgeons of British Columbia. (2022, May). Safer prescribing of opioids and sedatives https:\/\/www.cpsbc.ca\/files\/pdf\/PSG-Safe-Prescribing.pdf."},{"issue":"34","key":"10.1016\/j.josat.2024.209341_bb0160","doi-asserted-by":"crossref","first-page":"E967","DOI":"10.1503\/cmaj.200191","article-title":"Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada","volume":"192","author":"Crabtree","year":"2020","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.josat.2024.209341_bb0165","series-title":"Designing and conducting mixed methods research","author":"Creswell","year":"2017"},{"issue":"1","key":"10.1016\/j.josat.2024.209341_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implementation Science"},{"issue":"2","key":"10.1016\/j.josat.2024.209341_bb0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: No easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2024.209341_bb7000","author":"Doctors of BC"},{"issue":"6","key":"10.1016\/j.josat.2024.209341_bb0180","doi-asserted-by":"crossref","first-page":"e2216726","DOI":"10.1001\/jamanetworkopen.2022.16726","article-title":"Long-term risk of overdose or mental health crisis after opioid dose tapering","volume":"5","author":"Fenton","year":"2022","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.josat.2024.209341_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2307\/3343343","article-title":"Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada","volume":"21","author":"Fischer","year":"2000","journal-title":"Journal of Public Health Policy"},{"key":"10.1016\/j.josat.2024.209341_bb0190","doi-asserted-by":"crossref","unstructured":"Fischer, B., & Robinson, T. The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy. Pharmacoepidemiology and Drug Safety, n\/a(n\/a). doi:https:\/\/doi.org\/10.1002\/pds.5748.","DOI":"10.1002\/pds.5748"},{"issue":"1","key":"10.1016\/j.josat.2024.209341_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13011-022-00494-y","article-title":"Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada","volume":"17","author":"Foreman-Mackey","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2024.209341_bb0200","article-title":"\u201cCOVID just kind of opened a can of whoop-ass\u201d: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada","volume":"106","author":"Glegg","year":"2022","journal-title":"International Journal ot Drug Policy"},{"issue":"9","key":"10.1016\/j.josat.2024.209341_bb0205","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jama.2022.1271","article-title":"Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation","volume":"327","author":"Gomes","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.josat.2024.209341_bb0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/ADM.0000000000000928","article-title":"Trends in hospitalizations for serious infections among people with opioid use disorder in Ontario, Canada","volume":"16","author":"Gomes","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2024.209341_bb0215","unstructured":"Government, B. C. (2018, April 4). Nurse practitioners to play critical role saving lives in overdose crisis. https:\/\/news.gov.bc.ca\/releases\/2018MMHA0005-000564."},{"key":"10.1016\/j.josat.2024.209341_bb0220","author":"Government of British Columbia"},{"key":"10.1016\/j.josat.2024.209341_bb0225","author":"Government of British Columbia"},{"key":"10.1016\/j.josat.2024.209341_bb0230","author":"Government of British Columbia"},{"key":"10.1016\/j.josat.2024.209341_bb0235","unstructured":"Government of Canada. (2022, March 17). Safer supply: The difference between safer supply and opioid agonist therapy. https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/responding-canada-opioid-crisis\/safer-supply.html#a5."},{"key":"10.1016\/j.josat.2024.209341_bb0240","unstructured":"Government of Canada, M. o. J. (2023). Canada: Controlled Drugs and Substances Act https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-38.8\/."},{"key":"10.1016\/j.josat.2024.209341_bb0245","unstructured":"Health Canada. (2020). Frequently asked questions: Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada. Retrieved from https:\/\/www.canada.ca\/en\/health-canada\/services\/health-concerns\/controlled-substances-precursor-chemicals\/policy-regulations\/policy-documents\/section-56-1-class-exemption-patients-pharmacists-practitioners-controlled-substances-covid-19-pandemic\/frequently-asked-questions.html."},{"key":"10.1016\/j.josat.2024.209341_bb0250","doi-asserted-by":"crossref","unstructured":"Irvine M, Kuo M, Buxton J, Balshaw R, Otterstatter M, MacDougall L, Milroy, M. J., Bharmal, A., Henry, B., Tyndall, M., Coombs, D., & Gilbert, M. (2019). Modelling the combined impact of intervention in averting deaths during a synthetic-opioid overdose epidemic. Addiction, 114(9), 1602\u20131613. doi:https:\/\/doi.org\/10.1111\/add.14664.","DOI":"10.1111\/add.14664"},{"key":"10.1016\/j.josat.2024.209341_bb0120","author":"Health Canada"},{"key":"10.1016\/j.josat.2024.209341_bb0255","doi-asserted-by":"crossref","first-page":"102769","DOI":"10.1016\/j.drugpo.2020.102769","article-title":"Tackling the overdose crisis: The role of safe supply","volume":"80","author":"Ivsins","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209341_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108202","article-title":"Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: A qualitative study","volume":"216","author":"Ivsins","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2024.209341_bb0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11524-020-00489-9","article-title":"\u201cIt\u2019s helped me a lot, just like to stay alive\u201d: A qualitative analysis of outcomes of a novel hydromorphone tablet distribution program in Vancouver, Canada","volume":"98","author":"Ivsins","year":"2021","journal-title":"Journal of Urban Health"},{"issue":"5","key":"10.1016\/j.josat.2024.209341_bb0270","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.drugpo.2006.05.008","article-title":"Drug-related overdoses within a medically supervised safer injection facility","volume":"17","author":"Kerr","year":"2006","journal-title":"International Journal of Drug Policy"},{"issue":"6\u20137","key":"10.1016\/j.josat.2024.209341_bb0275","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00981389.2021.1953207","article-title":"Employing telehealth strategies for opioid addiction during COVID-19: Implications for social work health care","volume":"60","author":"Kim","year":"2021","journal-title":"Social Work in Health Care"},{"issue":"1","key":"10.1016\/j.josat.2024.209341_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-020-00372-5","article-title":"Practices of care among people who buy, use, and sell drugs in community settings","volume":"17","author":"Kolla","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10.1016\/j.josat.2024.209341_bb0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1332\/174426420X15913559981103","article-title":"Making evidence and policy in public health emergencies: Lessons from COVID-19 for adaptive evidence-making and intervention","volume":"16","author":"Lancaster","year":"2020","journal-title":"Evidence and Policy"},{"issue":"1","key":"10.1016\/j.josat.2024.209341_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12954-022-00614-8","article-title":"The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: A case study","volume":"19","author":"Lew","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2024.209341_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103363","article-title":"Opioid prescribing practice standard in British Columbia, Canada: Rationale, controversies, and directions","volume":"97","author":"Lim","year":"2021","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209341_bb0300","first-page":"1","article-title":"Just have this come from their prescription pad: The medicalization of safer supply from the perspectives of health planners in BC, Canada","author":"Macevicius","year":"2023","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"2","key":"10.1016\/j.josat.2024.209341_bb0305","first-page":"97","article-title":"Fourth wave of opioid (illicit drug) overdose deaths and diminishing access to prescription opioids and interventional techniques: Cause and effect","volume":"25","author":"Manchikanti","year":"2022","journal-title":"Pain Physician"},{"key":"10.1016\/j.josat.2024.209341_bb0310","doi-asserted-by":"crossref","unstructured":"Marshall, B. D. L., Milloy, M. J., Wood, E., Montaner, J. S. G., & Kerr, T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. The Lancet, 377(9775), 1429\u20131437. doi:https:\/\/doi.org\/10.1016\/S0140-6736(10)62353-7.","DOI":"10.1016\/S0140-6736(10)62353-7"},{"key":"10.1016\/j.josat.2024.209341_bb0315","unstructured":"McMurchy, D., & Palmer, R. W. H. (2022). Early findings from safer supply pilot projects. Ottawa, Ontario: Health Canada Retrieved from https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/responding-canada-opioid-crisis\/safer-supply\/early-findings-safer-supply-pilot-projects.html."},{"key":"10.1016\/j.josat.2024.209341_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103548","article-title":"Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic\u2013Is an update of legal restrictions warranted?","volume":"101","author":"Meyer","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.josat.2024.209341_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048353","article-title":"Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: A mixed-method study protocol","volume":"11","author":"Nosyk","year":"2021","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.josat.2024.209341_bb0335","first-page":"77","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"36","author":"Oviedo-Joekes","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.josat.2024.209341_bb0340","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2024.209341_bb0325","unstructured":"Ministry of Public Safety and Solicitor General (PSSG) [creator] (2018): BC corrections dataset. British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0345","unstructured":"Perinatal Services BC [creator] (2018): British Columbia Perinatal Data Registry. British Columbia Ministry of Health [publisher]. Data extract. MOH (2018). http:\/\/www.health.gov.bc.ca\/data\/."},{"key":"10.1016\/j.josat.2024.209341_bb0350","doi-asserted-by":"crossref","unstructured":"Piske, M., Zhou, H., Min, J. E., Hongdilokkul, N., Pearce, L. A., Homayra, F., Socias, M. E., McGowan, G., & Nosyk, B. (2020). The cascade of care for opioid use disorder: A retrospective study in British Columbia, Canada. Addiction. doi:https:\/\/doi.org\/10.1111\/add.14947.","DOI":"10.1111\/add.14947"},{"key":"10.1016\/j.josat.2024.209341_bb0355","author":"Province of British Columbia"},{"key":"10.1016\/j.josat.2024.209341_bb0360","unstructured":"Public Health Agency of Canada. (December, 2023). Apparent opioid and stimulant toxicity deaths: Surveillance of opioid and stimulant-related harms in Canada (January, 2016 - June, 2023). Ottawa: Public Health Agency of Canada Retrieved from https:\/\/health-infobase.canada.ca\/src\/doc\/SRHD\/Update_Deaths_2023-12.pdf."},{"key":"10.1016\/j.josat.2024.209341_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112488","article-title":"Evidence-making interventions in health: A conceptual framing","volume":"238","author":"Rhodes","year":"2019","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2024.209341_bb0370","doi-asserted-by":"crossref","unstructured":"Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, M. (2016). Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014. Morbidity and mortality weekly report. Department of Health and Human Services. In (Vol. 64, pp. 1378\u20131382.): Centre for Disease Control (CDC).","DOI":"10.15585\/mmwr.mm6450a3"},{"key":"10.1016\/j.josat.2024.209341_bb0375","doi-asserted-by":"crossref","unstructured":"Slaunwhite, A., Min, J., Palis, H., Urbanoski, K., Pauly, B., Barker, B., Crabtree, A., Bach, P., Krebs, E., Dale, L., L., M., & B., N. (2024). Evaluating the effects of risk mitigation guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: Retrospective cohort study. British Medial Journal, 384. doi:https:\/\/doi.org\/10.1136\/bmj-2023-076336.","DOI":"10.1136\/bmj-2023-076336"},{"key":"10.1016\/j.josat.2024.209341_bb0380","series-title":"Knowledge update: Post-mortem detection of hydromorphone among persons identified as having an illicit drug toxicity death since the introduction of risk mitigation guidance prescribing","author":"Slaunwhite","year":"2021"},{"issue":"1","key":"10.1016\/j.josat.2024.209341_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-3-30","article-title":"An organizational framework and strategic implementation for system-level change to enhance research-based practice: QUERI series","volume":"3","author":"Stetler","year":"2008","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2024.209341_bb0390","author":"The College of Physicians and Surgeons"},{"issue":"3","key":"10.1016\/j.josat.2024.209341_bb0395","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/medu.14380","article-title":"Interpretive description: A flexible qualitative methodology for medical education research","volume":"55","author":"Thompson Burdine","year":"2021","journal-title":"Medical Education"},{"key":"10.1016\/j.josat.2024.209341_bb0400","series-title":"Interpretive description: Qualitative research for applied practice","author":"Thorne","year":"2016"},{"key":"10.1016\/j.josat.2024.209341_bb0405","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1098-240X(199704)20:2<169::AID-NUR9>3.0.CO;2-I","article-title":"Interpretive description: A noncategorical qualitative alternative for developing nursing knowledge","volume":"20","author":"Thorne","year":"1997","journal-title":"Research in Nursing and Health"},{"key":"10.1016\/j.josat.2024.209341_bb0410","series-title":"The history of harm reduction","author":"Toward The Heart","year":"2018"},{"key":"10.1016\/j.josat.2024.209341_bb0415","article-title":"History of naloxone kits in BC: From inception to expansion","volume":"122","author":"Tsang","year":"2021","journal-title":"Diagnosis and Treatment of Ectopic Pregnancy"},{"key":"10.1016\/j.josat.2024.209341_bb0420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugpo.2019.01.017","article-title":"The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency","volume":"66","author":"Wallace","year":"2019","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209341_bb0425","author":"Watson"},{"key":"10.1016\/j.josat.2024.209341_bb0430","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.03.014","article-title":"Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015","volume":"45","author":"Wild","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209341_bb0435","unstructured":"Xavier, J., P.B., M., McDougall, J., Lamb, J., Streukens, A., Haywood, B., Scott, T., Lock, K., Ackermann, E., Loyal, J., Ferguson, M., Liu, L., Kamal, A., Greer, A., Butler, A., Iammarino, S., Palis, H., Slaunwhite, A., & Buxton, J. (2023). Substance use patterns and safer supply preferences among people who use drugs in British Columbia."}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:47:14Z","timestamp":1728622034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":86,"alternative-id":["S2949875924000535"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209341","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209341"}}